Skip to main content
. 2014 Jan 23;5(1):e1018. doi: 10.1038/cddis.2013.548

Figure 1.

Figure 1

The p53 structure with different protein domains (transactivation domain, proline-rich domain, DNA-binding domain, oligomerisation domain and regulation domain). Vertical lines indicate the occurrence of mutation of the amino acid residues in HNSCC (data from COSMIC website: cancer.sanger.ac.uk/cancergenome/projects/cosmic)